These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Efficacy and safety of thrombolytic therapy in the elderly with severe pulmonary embolism]. Meneveau N, Schiele F, Bouras Y, Mouhat T, Anguenot T, Bernard Y, Bassand JP. Arch Mal Coeur Vaiss; 1995 Jun 28; 88(6):825-31. PubMed ID: 7646295 [Abstract] [Full Text] [Related]
30. [Indications and results of thrombolytic treatment with urokinase of very severe pulmonary embolism]. Brochier M, Raynaud R, Griguer P, Faucchier JP, Morand P. Boll Soc Ital Cardiol; 1973 Jun 28; 18(7):693-6. PubMed ID: 4620067 [No Abstract] [Full Text] [Related]
32. The clinical use of fibrinolytic agents. Porter JM, Goodnight SH. Am J Surg; 1977 Aug 28; 134(2):217-21. PubMed ID: 889035 [Abstract] [Full Text] [Related]
34. Thrombolytic therapy: an introduction and review. Thiagarajan D. J Kans Med Soc; 1980 Jun 28; 81(6):292-3. PubMed ID: 6995538 [No Abstract] [Full Text] [Related]
37. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Dalen JE, Alpert JS, Hirsh J. Arch Intern Med; 1980 Jun 28; 157(22):2550-6. PubMed ID: 9531222 [No Abstract] [Full Text] [Related]
38. The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study. Sasahra AA, Bell WR, Simon TL, Stengle JM, Sherry S. Thromb Diath Haemorrh; 1975 Jun 30; 33(3):464-76. PubMed ID: 1098216 [Abstract] [Full Text] [Related]